STAT+: Genetic reprogramming rejuvenates nerve cells and restores vision in mice
For years now, biologists have been practicing a kind of time travel. You can take…
Author: STAT
Opinion: Misguided federal regulations are likely to cause more pain in people already living with it
Hidden in the shadows of the Covid-19 pandemic is the U.S.’s drug epidemic, which is…
STAT+: Pharmalittle: U.K. approves Pfizer Covid-19 vaccine; Trump pressures FDA to approve Covid-19 shots
Rise and shine, everyone, another busy day is on the way. In fact, the middle…
U.K. approves Pfizer’s Covid-19 vaccine, putting pressure on FDA
The United Kingdom on Wednesday became the first country to approve a Covid-19 vaccine developed…
.jpg)
Opinion: Better collection, reporting of race and ethnicity data are essential for fighting Covid-19
This year has challenged Americans to confront their understanding of society and to start rewriting…
Opinion: Advice for the next CMS administrator’s first 100 days
This week four years ago, I was working for the Centers for Medicare and Medicaid…
The Covid-19 vaccines are a marvel of science. Here’s how we can make the best use of them
It appears science may have found the Covid-19 pandemic’s off-ramp. Two vaccines developed with stunning…
Health workers, long-term care facilities should get Covid-19 vaccine first, CDC advisory panel says
A committee that advises the Centers for Disease Prevention and Control voted overwhelmingly on Tuesday…
STAT+: Ovid’s treatment for a rare, untreatable disease fails in a key trial
Ovid Therapeutics’ experimental drug for a devastating rare disease proved no better than placebo in…
How nanotechnology helps mRNA Covid-19 vaccines work
While the first two Covid-19 vaccines relying on messenger RNA technology speed toward regulatory approval…
STAT+: STAT+ Conversations: A conversation on drug pricing, policy, and access
Every week, STAT+ subscribers get access to exclusive conversations with biotech, pharma and health tech…
White House to host Covid-19 vaccine summit, as Trump seeks to burnish record
The Trump administration has invited leading vaccine manufacturers, drug distributors, and government officials to a…
STAT+: Pharmalittle: Serum Institute threatens to sue Covid-19 vaccine trial participant; U.S. agency prepares for Covid-19 vaccine fraud
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Agios drug for rare form of anemia achieves main goal of late-stage clinical trial
Agios Pharmaceuticals said Tuesday that its experimental drug mitapivat increased hemoglobin levels in patients with…
Opinion: The U.S. must support access to care and incentives for the innovation that transforms it
The deadly spread of Covid-19 around the world has highlighted the importance of innovation and…
STAT+: Legend Biotech believes it is not a target of Chinese investigation, CEO says
The new CEO of Legend Biotech says the company has seen no indication that it…
STAT+: Burr, in line to lead Senate Republicans’ health strategy, has a long history of antagonizing the FDA
WASHINGTON — Ask some key public health officials, and they’ll warn you that next year,…
The PPE crisis didn’t go away: Across the U.S., grassroots supply networks are trying to fill the void
Christine Garcia was scrambling. As the San Francisco regional director at an agency for children…
STAT+: FDA spikes a drug approval program that inadvertently led to price hikes and shortages
After years of mounting criticism, the federal government is planning to end a controversial program…
DeepMind’s protein-folding AI stuns with a solution to one of biology’s biggest challenges
At the start of a biennial contest to predict the structure of proteins, the expectations…
STAT+: Medicines Patent Pool expands deal for access to key HIV drug to several countries
In a bid to expand access to a key AIDS drug, ViiV Healthcare and the…
STAT+: Pharmalittle: Moderna seeking regulatory clearance for Covid-19 vaccine; charter flights begin for Pfizer vaccine
Good morning, everyone, and nice to see you again after an extended holiday break on…
STAT+: Startup Spotlight: Bullish on its asthma treatment, Kinaset forges ahead in unusual times
Launching a clinical trial for a drug intended to treat severe asthma during a respiratory…
Moderna to submit Covid-19 vaccine to FDA as full results show 94% efficacy
Moderna said Monday that its Covid-19 vaccine continued to deliver strong efficacy results, showing 94%…
Divisions emerge among U.S. officials over when first Covid-19 vaccine doses will be available — and for whom
Divisions are emerging among top U.S. officials over when the country’s first Covid-19 vaccine will…
Opinion: Every state needs emergency regulations to protect essential food workers
The darkest days of the pandemic are still ahead of us, as we head into…
STAT+: ‘How are we going to get on that plane?’: The transatlantic race to deliver CAR-T cancer therapy during the pandemic
On the evening that would jolt the global traffic of cancer treatments, David Kim was…
How much did Thanksgiving contribute to Covid-19 spread? It’s wait and see for now
And now we wait. Thanksgiving is over, and public health officials’ persistent warnings that large…
STAT+: In major bet, Biogen pays $1.5 billion for rights to a once-failed treatment for depression
Biogen, placing a major bet on a once-failed treatment, is paying $1.53 billion for the…
Opinion: I worked hard to protect myself from Covid-19 and the flu. Yet I got both — at the same time
My painful excursion into the world of dueling infections started on a Tuesday afternoon with…
Opinion: Rethinking Black Friday to include end-of-life conversations
With more than 250,000 Americans killed by Covid-19, it’s time to think about reimagining Black…
Mask defiance remains strong in Big Sky Country, even as the pandemic rages
A cancer survivor vulnerable to serious illness, Chany Reon worried as the coronavirus swept through…
Opinion: Add Covid-related myocarditis, mechanical ventilation, and death to this year’s football risks
Our fourth annual Football Injury Highlight Reel is taking a different tack this year. In…
Study offers new clues for treating brain cancer in children
Brain tumors are among the most common — and the most deadly — cancers among…
STAT+: House committee wants Purdue CEO and Sackler family members to testify at opioid crisis hearing
A congressional committee has asked the chief executive officer of Purdue Pharma and some members…
STAT+: Pharmalittle: Purdue pleads guilty to opioid charges; Chinese firm files for Covid-19 vaccine approval
Good morning, everyone. Damian Garde here, filling in for Ed Silverman on the last work…
Opinion: What the biopharma industry is doing to build confidence in Covid-19 vaccines
Over the last few weeks, the United States has surpassed 100,000 Covid-19 cases a day…
Opinion: Beyond burnout: For health care workers, this surge of Covid-19 is bringing burnover
Covid-19 is roaring back for a third wave. The first two substantially increased feelings of…
STAT+: ‘The trend is irreversible’: How Covid-19 could drive a shift toward decentralized trials
Covid-19 started as a disaster for clinical research, halting or delaying 3 of every 4…
A ‘bad case of déjà vu’: New Jersey hospitals brace for Covid-19 surge, but hope this time will be different
The first round of treating Covid-19 patients in New Jersey was brutal. Victorine Long Njaka,…
STAT+: Alnylam wins FDA approval for first drug to treat rare kidney disease
Alnylam Pharmaceuticals Inc. scored its third approval from the US Food and Drug Administration in…
STAT+: Which pricey drugs will Trump’s international pricing policy target?
A version of this story first appeared in D.C. Diagnosis, STAT’s weekly newsletter about the…
STAT+: Pharmalittle: EU plots a crackdown on delay of generic drugs; Russia says its Covid-19 vaccine is 95% effective
Good morning, one and all. Damian Garde here, filling in for Ed Silverman in the…
Opinion: OSHA’s ‘absurd reinterpretation’ of a regulation regarding workers and Covid-19
Workplace exposures continue to be a major driver of the coronavirus pandemic, something that the…
Opinion: Now is the time to innovate for more than 1 billion people with neglected tropical diseases
With the first results of multiple Covid-19 vaccine candidates giving hope to billions of people…
As a kid, his factory work paid for his dad’s cancer care. As an oncologist, his research offers more than survival
No one knows when, exactly, Mutlay Sayan was born. His mother told him it was…
‘Essential workers’ likely to get earlier access to Covid-19 vaccine
Essential workers are likely to move ahead of adults 65 and older and people with…
Opinion: CMS’s new rules on organ donation and transplantation ‘will bring chaos’
The United States had a once-in-a-generation opportunity to save countless additional lives each year by…
STAT+: A new startup wants to use natural killer cells to fight cancer
On a blustery day last December, five biotech entrepreneurs and scientists walked past the snow-draped…
STAT+: Pharmalittle: AstraZeneca says its vaccine cuts Covid-19 risk by 70%; U.S. shots will ‘hopefully’ start within three weeks
Good morning. I’m Elizabeth Cooney, filling in for Ed Silverman today as he prepares to…